share_log

8-K: Current report

SEC ·  Jul 2 19:34
Summary by Futu AI
On June 28, 2024, SeaStar Medical Holding Corporation entered into a warrant redemption agreement with an institutional investor to redeem all 126,330 warrants for purchasing the company's common stock. The warrants were initially issued as part of a securities purchase agreement on March 15, 2023. SeaStar Medical will pay a total of $449,734.80 for the redemption, with $100,000 paid on July 1, 2024, and the remaining $349,734.80 due by August 27, 2024, accruing interest at 7% per annum. This redemption satisfies all obligations under the original purchase agreement and associated notes, with no further obligations or rights remaining except those that survive the termination of the agreements.
On June 28, 2024, SeaStar Medical Holding Corporation entered into a warrant redemption agreement with an institutional investor to redeem all 126,330 warrants for purchasing the company's common stock. The warrants were initially issued as part of a securities purchase agreement on March 15, 2023. SeaStar Medical will pay a total of $449,734.80 for the redemption, with $100,000 paid on July 1, 2024, and the remaining $349,734.80 due by August 27, 2024, accruing interest at 7% per annum. This redemption satisfies all obligations under the original purchase agreement and associated notes, with no further obligations or rights remaining except those that survive the termination of the agreements.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1

Doc 2

The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content. It is only available to users located outside of China mainland.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.